Jingwei Li
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Editorial: Hospital acquired infection in patients with cardiovascular diseases.
Journal: Frontiers in medicine
Published: January 14, 2026
Correction: Effect of the renin-angiotensin-aldosterone system inhibitors on time to nucleic acid negative conversion in hypertensive patients with SARS-CoV-2 omicron infection: a propensity score matching study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: October 03, 2025
The effect of urban-rail station area coverage on city blocks' epidemic transmission: the case of the rail-supportive city of Beijing, China.
Journal: Frontiers in public health
Published: March 05, 2025
Correction: Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway.
Journal: BMC cardiovascular disorders
Published: October 05, 2024
Effect of the renin-angiotensin-aldosterone system inhibitors on time to nucleic acid negative conversion in hypertensive patients with SARS-CoV-2 omicron infection: a propensity score matching study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 08, 2024
The association between sodium-glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study.
Journal: European journal of medical research
Published: March 03, 2024
Impact of guideline-directed medical therapy on systolic blood pressure and cardiovascular outcomes in patients with heart failure and low blood pressure: A systematic review and meta-analysis.
Journal: European journal of heart failure
Published: March 01, 2024
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial.
Journal: Circulation
Published: August 21, 2023
Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway.
Journal: BMC cardiovascular disorders
Published: April 27, 2023
Editorial: New mechanisms and drugs for the treatment of cardiovascular disease with diabetes.
Journal: Frontiers in cardiovascular medicine
Published: January 15, 2023
Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.
Journal: Diabetes, obesity & metabolism
Published: March 16, 2022
Exploring the Relationship Between Neighborhood-Built Environment and Elderly Health: A Research Based on Heterogeneity of Age and Gender Groups in Beijing.
Journal: Frontiers in public health
Published: February 23, 2022
Last Updated: 09/26/2026